Challenges in integration and integrated care: psychedelic assisted therapies for addiction and mental illness

Presented by A/Prof Shalini Arunogiri. By the end of this webinar, attendees will be able to: Understand the current evidence base for the use of MDMA and psilocybin in addiction and related mental health problems; Understand key evidence gaps in existing evidence in psychedelic-assisted therapies; Identify and critically appraise challenges with implementation of psychedelic-assisted therapies in Australia.